Stock screener
All disclosures →
EDGAR →
AMGN
Conviction 86HealthcareScan · Thu, Sep 24, 2026Amgen Inc (AMGN) closed at $406.13 (+0.01%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 52, RS Rating 87, -8.6% from its 52-week high, +24.0% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
AMGN$406.13+0.01%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
Vol MA14 3.57M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +0.00%· 1 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price406.13
Change+0.01%
Gap+0.26%
Rel volume1.30×
Avg volume3.12M
Avg $ vol1.25B
SMA 20406.02
SMA 50403.84
SMA 200361.66
Price vs 50+0.57%
Price vs 200+12.30%
MA stackbullish
50/200 cross—
Supertrendup · 376.92
RSI (14)52
MACD hist0.45
MACD crossbull · 0d
Stoch %K / %D47 / 47
ADX (14)31
+DI / −DI31 / 23
RSI divergenceBearish
MACD divergenceBearish
ATR %2.60%
ADR %2.21%
52w high444.12
52w low271.18
From 52w high-8.55%
Above 52w low+49.76%
New 52w highNo
SqueezeOff
Bollinger width24.62%
%B0.50
Donchian pos44.38%
Donchian high445.82
Donchian low374.46
AVWAP (52w high)403.60
vs AVWAP high+0.63%
AVWAP (52w low)351.98
vs AVWAP low+15.38%
OBV trendFlat
Chaikin MF (20)-0.02
Today vs 20d1.30×
Avg vol (14d)3.57M
Avg vol (20d)3.12M
Avg $ vol (20d)1.25B
Market cap219.57B
RS Rating87 / 99
RS 3m (vs SPY)+10.62%
RS 6m (vs SPY)-2.07%
RS line new highNo
Trend template8/8
Technical rank70.7
1 week+6.94%
1 month-8.17%
3 months+15.11%
6 months+14.75%
1 year+41.60%
YTD+23.96%
P/E28.47
P/B18.79
P/S5.97
P/FCF27.11
EPS14.23
Div yield2.33%
ROE65.97%
ROA8.06%
Debt/Eq4.90
Current1.37
EV/EBITDA18.45
Gross margin12.89%
Net margin20.98%
Rev growth9.95%
EPS growth88.53%
Price target399.22
Target upside-1.70%
Analyst ratingHold
Institutional93.55%
Ent. value262.88B
Revenue10.05B
Net income2.38B
Gross profit—
Free cash flow8.1B
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out539.71M
Employees31.5K
ListedFri, Jun 17, 1983
Free float537.53M
Float %99.6%
Short interest12.97M
Days to cover5.6d
Short volume65.1%
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est$6.29 vs $5.60
Last surprise+12.3% beat
Setup gradeA
Conviction86 / 100
Pattern quality—
Tech rank70.7 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance445.35
Support375.21
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Amgen stock surges on positive Sjögren’s trial resultsInvesting.com · Tue, Sep 22, 2026
- Amgen posts trial win for Sjögren's disease drug (AMGN:NASDAQ)Seeking Alpha · Tue, Sep 22, 2026
- AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASEYahoo Finance · Tue, Sep 22, 2026
- Amgen stock gains 1.95 percent as estimates face pressureAD HOC NEWS · Tue, Sep 22, 2026
- Capitalize on the PEGylated Proteins Revenue Shift: Benchmark Amgen, Roche, Merck KGaA, Pfizer and Novo Nordisk to Secure Competitive ROI Through the Forecast PeriodYahoo Finance · Tue, Sep 22, 2026
- Amgen stock heads into the open after a 1.95 percent gainAD HOC NEWS · Tue, Sep 22, 2026
- Morgan Stanley flags Amgen's edge after heart-drug rival stumblesTheStreet · Tue, Sep 22, 2026
- Amgen stock ends the day 1.95 percent higher at the closeAD HOC NEWS · Mon, Sep 21, 2026
- Veeva Expands Amgen Partnership With Global Vault CRM Rollout PlanYahoo Finance · Mon, Sep 21, 2026
- The Zacks Analyst Blog Highlights AMD, Linde, Amgen and INNOVATEYahoo Finance · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in AMGN · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
David J. Taylor house · R · OH · traded 2026-08-26 | Sell | $1K–$15K | 2026-08-26 | 2026-09-05 | |
Sheldon Whitehouse senate · D · RI · traded 2026-08-12 | Sell | $1K–$15K | 2026-08-12 | 2026-09-02 | |
 Thomas H Tuberville senate · traded 2025-04-15 | Sell | $15K–$50K | 2025-04-15 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Sell | $15K–$50K | 2026-03-27 | 2026-07-21 | |
David J. Taylor house · R · OH · traded 2026-06-05 | Buy | $1K–$15K | 2026-06-05 | 2026-06-12 | |
David J. Taylor house · OH · traded 2026-02-26 | Sell | $1K–$15K | 2026-02-26 | 2026-03-05 | |
David J. Taylor house · OH · traded 2026-01-16 | Buy | $1K–$15K | 2026-01-16 | 2026-01-30 | |
David J. Taylor house · OH · traded 2025-12-03 | Sell | $1K–$15K | 2025-12-03 | 2025-12-05 | |
 Marjorie Taylor Greene house · GA · traded 2025-10-24 | Buy | $1K–$15K | 2025-10-24 | 2025-10-28 | |
 Lisa McClain house · R · MI · traded 2025-09-25 | Sell | $1K–$15K | 2025-09-25 | 2025-10-22 |
Insider activity
SEC Form 4 transactions in AMGN · open-market 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Khosla Rachna SVP, Business Development · Nqso (Right to Buy) · 2026-08-13 | Exercise | 1.25K | — | 2026-08-13 | 2026-08-13 |
Khosla Rachna SVP, Business Development · Common Stock · 2026-08-13 | Sell | 1.25K | $521K | 2026-08-13 | 2026-08-13 |
Khosla Rachna SVP, Business Development · Common Stock · 2026-08-13 | Exercise | 1.25K | $204K | 2026-08-13 | 2026-08-13 |
Khosla Rachna SVP, Business Development · Common Stock · 2026-08-11 | Sell | 2K | $825K | 2026-08-11 | 2026-08-13 |
Busch Matthew C. VP, Finance & CAO · Common Stock · 2026-08-07 | Grant | 730 | — | 2026-08-07 | 2026-08-12 |
ISHRAK OMAR Director · Common Stock · 2026-08-07 | Grant | 85.169 | — | 2026-08-07 | 2026-08-10 |
HOLLEY CHARLES M Director · Common Stock · 2026-08-07 | Grant | 103.419 | — | 2026-08-07 | 2026-08-10 |
Drake Michael V Director · Common Stock · 2026-08-07 | Grant | 63.876 | — | 2026-08-07 | 2026-08-10 |
Miller Derek SVP, Human Resources · Common Stock · 2026-08-06 | Exercise | 2.07K | $336K | 2026-08-06 | 2026-08-07 |
Miller Derek SVP, Human Resources · Common Stock · 2026-08-06 | Exercise | 1.82K | $323K | 2026-08-06 | 2026-08-07 |
SEC filings
EDGAR filings in AMGN · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.